28 March 2013
Bookmark and Share

WADA statement on recent CAS decision on hGH

The World Anti-Doping Agency (WADA) has now had the opportunity to carefully study the decision rendered by the Court of Arbitration for Sport (CAS) on March 26th 2013 in the case of Mr. Andrus Veerpalu. 

WADA regrets the outcome of this case, where according to the CAS panel in its decision“ there are many factors in this case which tend to indicate that the Athlete did in fact administer exogenous hGH”. It means to WADA that a likely cheater has evaded a sanction due to a tenuous technicality. WADA is deeply disappointed with this situation, but acknowledges the CAS authority and understands that the panel was not comfortably satisfied with the decision limits (DL) currently applied to the hGH test. WADA will immediately engage in a process to re-establish these limits taking into account the remarks expressed in the CAS award.

WADA is pleased however that CAS has fully accepted that the test itself is reliable and indicated “the Respondent has shown to the comfortable satisfaction of this Panel that the hGH Test is a reliable testing method for hGH abuse in professional sports that is based on scientifically correct assumptions and methods”.

 WADA will therefore encourage Anti-Doping Organizations (ADOs) to continue collecting samples for analysis pursuant to the hGH test and will, based on the larger number of samples now available, advise on revised decision limits shortly.